BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2842403)

  • 1. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections.
    Louv WC; Austin H; Alexander WJ; Stagno S; Cheeks J
    J Infect Dis; 1988 Sep; 158(3):518-23. PubMed ID: 2842403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections.
    Niruthisard S; Roddy RE; Chutivongse S
    Lancet; 1992 Jun; 339(8806):1371-5. PubMed ID: 1350804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? A meta-analysis.
    Cook RL; Rosenberg MJ
    Sex Transm Dis; 1998 Mar; 25(3):144-50. PubMed ID: 9524992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. A comparative clinical trial.
    Rosenberg MJ; Rojanapithayakorn W; Feldblum PJ; Higgins JE
    JAMA; 1987 May; 257(17):2308-12. PubMed ID: 3033339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: a randomized controlled trial.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Tweedy KG
    JAMA; 2002 Mar; 287(9):1117-22. PubMed ID: 11879108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal contraceptives. Effective protection from sexually transmitted diseases for women?
    North BB
    J Reprod Med; 1988 Mar; 33(3):307-11. PubMed ID: 2834553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contraceptive sponge's protection against Chlamydia trachomatis and Neisseria gonorrhoeae.
    Rosenberg MJ; Feldblum PJ; Rojanapithayakorn W; Sawasdivorn W
    Sex Transm Dis; 1987; 14(3):147-52. PubMed ID: 2821636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.
    Kreiss J; Ngugi E; Holmes K; Ndinya-Achola J; Waiyaki P; Roberts PL; Ruminjo I; Sajabi R; Kimata J; Fleming TR
    JAMA; 1992 Jul 22-29; 268(4):477-82. PubMed ID: 1320133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonoxynol-9 as a vaginal microbicide for prevention of sexually transmitted infections: it's time to move on.
    Richardson BA
    JAMA; 2002 Mar; 287(9):1171-2. PubMed ID: 11879115
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of the intravaginal insert (IVI): acceptability, side effects, and post-coital spermicidal activity.
    Ahmad M; Asch RH
    Acta Eur Fertil; 1984; 15(5):369-76. PubMed ID: 6099026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis.
    Barbone F; Austin H; Louv WC; Alexander WJ
    Am J Obstet Gynecol; 1990 Aug; 163(2):510-4. PubMed ID: 2167008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVO100 prevents chlamydia and gonorrhea in women at high risk of infection.
    Chappell BT; Mena LA; Maximos B; Mollan S; Culwell K; Howard B
    Am J Obstet Gynecol; 2021 Aug; 225(2):162.e1-162.e14. PubMed ID: 33705748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials.
    Moncla BJ; Hillier SL
    Sex Transm Dis; 2005 Aug; 32(8):491-4. PubMed ID: 16041251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Easing the way to safer sex.
    Larkin M
    Lancet; 1998 Mar; 351(9107):964. PubMed ID: 9734955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.
    Zeitlin L; Hoen TE; Achilles SL; Hegarty TA; Jerse AE; Kreider JW; Olmsted SS; Whaley KJ; Cone RA; Moench TR
    Sex Transm Dis; 2001 Jul; 28(7):417-23. PubMed ID: 11460027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
    Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
    Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia.
    Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC
    Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
    Richardson BA; Lavreys L; Martin HL; Stevens CE; Ngugi E; Mandaliya K; Bwayo J; Ndinya-Achola J; Kreiss JK
    Sex Transm Dis; 2001 Jul; 28(7):394-400. PubMed ID: 11460023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-9 film study a blow for microbicide research.
    AIDS Alert; 1997 Jun; 12(6):66-8. PubMed ID: 11364359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.